Cognitive Dysfunction: all 3,930 studies

Page 38 of 40. Open to participants first (1,114), then studies with results posted, then the rest; newest registration first within each.

• Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive ImpairmentStatus unknownNCT01464515Phase 1
• Self-management and Cognitive Function in Adults With Heart FailureCompletedNCT01461629
• Measuring the Impact of Cognitive and Psychosocial Interventions in Persons With Mild Cognitive ImpairmentCompletedNCT01448148Not applicable
• Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to DementiaStatus unknownNCT01436552
• A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's DiseaseCompletedNCT01436188Early Phase 1
• Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing InmatesCompletedNCT01428349Not applicable
• Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive ImpairmentCompletedNCT01425957Not applicable
• Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)CompletedNCT01421056Phase 2
• Cognitive Impairment , Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular DiseaseStatus unknownNCT01418885
• Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals.CompletedNCT01394796Phase 2
• Brain-derived Neurotrophic Factor and Cogntive FunctionStatus unknownNCT01390688
• NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)CompletedNCT01370954
• Cognitive Dysfunction in Postural Tachycardia SyndromeCompletedNCT01366963
• The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no DementiaCompletedNCT01363648Phase 4
• Childhood Anesthesia and Cognitive FunctionCompletedNCT01359215
• Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive ImpairmentCompletedNCT01358955Not applicable
• Vascular Alteration and Evolution of Cognitive ImpairmentCompletedNCT01351961Not applicable
• Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE StudyCompletedNCT01348282Phase 4
• Add On Treatment for Cognitive Deficits in SchizophreniaCompletedNCT01346163Phase 1
• Post-stroke Cognitive Impairment and DementiaCompletedNCT01339195Not applicable
• Dexamethasone for the Prevention of Postoperative Cognitive DysfunctionCompletedNCT01332812Phase 4
• Cognitive Impairment and Cardiovascular Risk in OlderCompletedNCT01327196
• FluoroAv45 Imaging Research-in Alzheimer's DiseaseCompletedNCT01325259Phase 2
• Peri-Anesthetic Imaging of Cognitive DysfunctionCompletedNCT01322672
• Home Care Medication Management Program for the Frail ElderlyCompletedNCT01321853Phase 1
• A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's DiseaseCompletedNCT01320527Phase 2
• Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related DisordersStatus unknownNCT01316562
• Gait and Alzheimer Interaction Tracking (GAIT) StudyCompletedNCT01315717
• Alzheimer's Disease and Related DisordersStatus unknownNCT01315704
• New Biomarker for Alzheimer's Disease DiagnosticCompletedNCT01315639Not applicable
• Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)Status unknownNCT01314638
• Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive ImpairmentWithdrawnNCT01309685Phase 1
• Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple SclerosisStatus unknownNCT01303770Not applicable
• Cognitive Rehabilitation in Patients With Spina BifidaCompletedNCT01302314Not applicable
• Can Exercise Improve Cancer Associated Cognitive Dysfunction?CompletedNCT01296893Phase 2
• Effects of rTMS on the Cognition of Elderly With Mild Memory ComplaintsStatus unknownNCT01292382Not applicable
• Caloric Restriction in Obese Patients With Mild Cognitive Impairment: Effects on Adiposity, Comorbidity and CognitionCompletedNCT01286389Not applicable
• A Rehabilitation Intervention for Amnestic Mild Cognitive ImpairmentCompletedNCT01283269Not applicable
• Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in AdultsCompletedNCT01266174Phase 2
• Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With NatalizumabStatus unknownNCT01250678
• Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple SclerosisStatus unknownNCT01250665
• The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)CompletedNCT01246804Phase 1
• Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy VolunteersStatus unknownNCT01238458Phase 2
• Alzheimer's Disease Neuroimaging Initiative 2CompletedNCT01231971
• Pilot Testing a New Computer-based Screening Tool to Detect Cognitive ImpairmentCompletedNCT01220674
• Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic StrokesStatus unknownNCT01220622Phase 4
• Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple SclerosisCompletedNCT01219647Phase 1/2
• Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)CompletedNCT01219244Phase 2/3
• Effects of Mental Stimulation in Patients With Mild Cognitive ImpairmentCompletedNCT01212692Phase 2
• A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's DiseaseCompletedNCT01211587Phase 2
• The Swedish BioFINDER StudyCompletedNCT01208675
• Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosisCompletedNCT01205464Not applicable
• The Effects of Diet on Mood, Cognition and AppetiteCompletedNCT01201616Not applicable
• POCD in Elderly Patients Following Desflurane or Sevoflurane General AnesthesiaCompletedNCT01199913
• Statin Therapy To Limit Cognitive Dysfunction After Cardiac SurgeryWithdrawnNCT01186289Not applicable
• Long-term Outcome of General Anesthesia on DysgnosiaStatus unknownNCT01184638Phase 4
• Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)CompletedNCT01181310Phase 1
• Effects of Dietary Nitrate From Vegetable/Fruit Juice on Cerebral Blood Flow ParametersCompletedNCT01169662Phase 4
• Early Cognitive Impairment in Multiple SclerosisCompletedNCT01157728
• Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
• Aerobic Exercise Training in Mild Cognitive Impairment StudyCompletedNCT01146717Not applicable
• Cognitive Dysfunction in Hypertensive Patients Having Spine SurgeryCompletedNCT01140854
• Trial of a Brain Preservation Diet in Preventing Cognitive Decline in Old Age Hostel ResidentsCompletedNCT01132261Not applicable
• The Effect of Physostigmine on Cognitive Functioning in the Immediate Period After Sedation for ColonoscopyStatus unknownNCT01121497Not applicable
• Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator PerformanceCompletedNCT01120860
• A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective DisorderCompletedNCT01116830Phase 1
• Austrian Polyintervention Study to Prevent Cognitive Decline After Ischemic StrokeCompletedNCT01109836Phase 4
• Postoperative Cognitive Dysfunction After Total Knee or Hip Replacement Surgery in Fast-track Set-upCompletedNCT01103752
• Change in Executive Function and IADL Using a Virtual Supermarket Environment Among People With MCIStatus unknownNCT01103453Phase 1
• Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's DiseaseStatus unknownNCT01099332Phase 1/2
• Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's DiseaseCompletedNCT01095744
• Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With SchizophreniaCompletedNCT01095562Phase 2
• Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's DiseaseCompletedNCT01094145Not applicable
• Study of the Correlation Between Specific Genes and Cognitive Dysfunction After SurgeryCompletedNCT01088100
• Alzheimer's Disease Neuroimaging Initiative Grand OpportunityCompletedNCT01078636
• Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaCompletedNCT01077700Phase 2
• Guidance for Elderly With Cognitive DisordersCompletedNCT01076855
• Study on Cognitive Disorders of Multiple SclerosisCompletedNCT01074619Phase 3
• Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive ImpairmentTerminatedNCT01072812Phase 1
• Sensory-cognitive and Physical Fitness Training in Mild Cognitive ImpairmentCompletedNCT01061489Not applicable
• Compensatory Strategies Applied to Cognitive Impairment in SchizophreniaCompletedNCT01055509Not applicable
• Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's DiseaseStatus unknownNCT01055392Phase 2
• Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCICompletedNCT01046292Phase 4
• Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing ChemotherapyWithdrawnNCT01045044
• Cognitive Function in Adults With Cardiac DiseaseCompletedNCT01043315
• Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and DisabilityActive, not recruitingNCT01041989Not applicable
• Cognitive Dysfunction After Aneurysmal Subarachnoid HaemorrhageCompletedNCT01038193
• PROMOTE: Promotion of the Mind Through ExerciseCompletedNCT01027858Not applicable
• Cognitive Training to Improve Cognitive Function Following ChemotherapyStatus unknownNCT01013233Not applicable
• Does Zumba Improve Cognition in Healthy APOE e4 Carriers and NoncarriersCompletedNCT01012791Not applicable
• Dysphagia in Elderly Medical PatientsCompletedNCT01006330
• TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in SchizophreniaCompletedNCT01003379Phase 2
• Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac SurgeryTerminatedNCT00991328Phase 3
• Determinants of Cognitive Impairment After Acute Coronary SyndromeCompletedNCT00982176Not applicable
• Passport to Brain Wellness in Sedentary AdultsCompletedNCT00979446Not applicable
• A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).TerminatedNCT00978536Not applicable
• EXCEL: Exercise for Cognition and Everyday Living for Seniors With Memory ComplaintsCompletedNCT00958867Not applicable
• Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702CompletedNCT00950586Phase 1
• Characterization of Factors Influencing the Cognitive Decline in Patients With Coronary Artery DiseaseCompletedNCT00946959Not applicable
• Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan StudyCompletedNCT00937846Phase 1

← Cognitive Dysfunction overview